These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24312251)

  • 21. Incorporation of Putative Helix-Breaking Amino Acids in the Design of Novel Stapled Peptides: Exploring Biophysical and Cellular Permeability Properties.
    Partridge AW; Kaan HYK; Juang YC; Sadruddin A; Lim S; Brown CJ; Ng S; Thean D; Ferrer F; Johannes C; Yuen TY; Kannan S; Aronica P; Tan YS; Pradhan MR; Verma CS; Hochman J; Chen S; Wan H; Ha S; Sherborne B; Lane DP; Sawyer TK
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31226791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.
    Ong ZY; Cheng J; Huang Y; Xu K; Ji Z; Fan W; Yang YY
    Biomaterials; 2014 Jan; 35(4):1315-25. PubMed ID: 24211081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationship of Trp-containing analogs of the antimicrobial peptide gomesin.
    Domingues TM; Buri MV; Daffre S; Campana PT; Riske KA; Miranda A
    J Pept Sci; 2014 Jun; 20(6):421-8. PubMed ID: 24706599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Biological and Biophysical Properties of the Spider Peptide Gomesin.
    Tanner JD; Deplazes E; Mancera RL
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30012962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cationic amphiphilic peptide ABP-CM4 exhibits selective cytotoxicity against leukemia cells.
    Chen YQ; Min C; Sang M; Han YY; Ma X; Xue XQ; Zhang SQ
    Peptides; 2010 Aug; 31(8):1504-10. PubMed ID: 20493915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structures of β-hairpin antimicrobial protegrin peptides in lipopolysaccharide membranes: mechanism of gram selectivity obtained from solid-state nuclear magnetic resonance.
    Su Y; Waring AJ; Ruchala P; Hong M
    Biochemistry; 2011 Mar; 50(12):2072-83. PubMed ID: 21302955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective killing of cancer cells by peptide-targeted delivery of an anti-microbial peptide.
    Sioud M; Mobergslien A
    Biochem Pharmacol; 2012 Nov; 84(9):1123-32. PubMed ID: 22922046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stapled Wasp Venom-Derived Oncolytic Peptides with Side Chains Induce Rapid Membrane Lysis and Prolonged Immune Responses in Melanoma.
    Wu Y; Lu D; Jiang Y; Jin J; Liu S; Chen L; Zhang H; Zhou Y; Chen H; Nagle DG; Luan X; Zhang W
    J Med Chem; 2021 May; 64(9):5802-5815. PubMed ID: 33844923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study on the effects of different dimerization positions on biological activity of partial d-Amino acid substitution analogues of Anoplin.
    Zhong C; Gou S; Liu T; Zhu Y; Zhu N; Liu H; Zhang Y; Xie J; Guo X; Ni J
    Microb Pathog; 2020 Feb; 139():103871. PubMed ID: 31733278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antifungal and antitumor models of bioactive protective peptides.
    Rodrigues EG; Dobroff AS; Taborda CP; Travassos LR
    An Acad Bras Cienc; 2009 Sep; 81(3):503-20. PubMed ID: 19722020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents.
    Tzitzilis A; Boura-Theodorou A; Michail V; Papadopoulos S; Krikorian D; Lekka ME; Koukkou AI; Sakarellos-Daitsiotis M; Panou-Pomonis E
    J Pept Sci; 2020 Jul; 26(7):e3254. PubMed ID: 32567085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gomesin acts in the immune system and promotes myeloid differentiation and monocyte/macrophage activation in mouse.
    Buri MV; Dias CC; Barbosa CM; Nogueira-Pedro A; Ribeiro-Filho AC; Miranda A; Paredes-Gamero EJ
    Peptides; 2016 Nov; 85():41-45. PubMed ID: 27614284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological evaluation of novel peptides based on antimicrobial peptides as potential agents with antitumor and multidrug resistance-reversing activities.
    Zhang B; Shi W; Li J; Liao C; Yang L; Huang W; Qian H
    Chem Biol Drug Des; 2017 Nov; 90(5):972-980. PubMed ID: 28524273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationships for the beta-hairpin cationic antimicrobial peptide polyphemusin I.
    Powers JP; Rozek A; Hancock RE
    Biochim Biophys Acta; 2004 May; 1698(2):239-50. PubMed ID: 15134657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design of nontoxic analogues of cathelicidin-derived bovine antimicrobial peptide BMAP-27: the role of leucine as well as phenylalanine zipper sequences in determining its toxicity.
    Ahmad A; Azmi S; Srivastava RM; Srivastava S; Pandey BK; Saxena R; Bajpai VK; Ghosh JK
    Biochemistry; 2009 Nov; 48(46):10905-17. PubMed ID: 19845398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Learning from host-defense peptides: cationic, amphipathic peptoids with potent anticancer activity.
    Huang W; Seo J; Willingham SB; Czyzewski AM; Gonzalgo ML; Weissman IL; Barron AE
    PLoS One; 2014; 9(2):e90397. PubMed ID: 24587350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unlocking the Potential of the Antimicrobial Peptide Gomesin: From Discovery and Structure-Activity Relationships to Therapeutic Applications.
    Liu X; Henriques ST; Craik DJ; Chan LY
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor activity of antimicrobial peptides containing CisoDGRC in CD13 negative breast cancer cells.
    Hou L; Zhao X; Wang P; Ning Q; Meng M; Liu C
    PLoS One; 2013; 8(1):e53491. PubMed ID: 23326440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptide motifs for cell-surface intervention: application to anti-infective and biopharmaceutical development.
    Monk BC; Harding DR
    BioDrugs; 2005; 19(4):261-78. PubMed ID: 16128608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arginine modification of lycosin-I to improve inhibitory activity against cancer cells.
    Zhang P; Ma J; Yan Y; Chen B; Liu B; Jian C; Zhu B; Liang S; Zeng Y; Liu Z
    Org Biomol Chem; 2017 Nov; 15(44):9379-9388. PubMed ID: 29090725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.